Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Israel
/
Corporate bonds
/
TEVA5034099
/
Analysis
T
T
T
Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025
TEVA5034099
FINRA
TEVA5034099
FINRA
TEVA5034099
FINRA
TEVA5034099
FINRA
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
TEVA5034099 analysis
Overview
Coupon
Redemption
Risks
More
Key facts
Issuer
Teva Pharmaceutical Finance Netherlands III BV
Issue date
Sep 14, 2020
Maturity date
Jan 31, 2025
Outstanding amount
425.26 M
USD
Face value
1,000.00
USD
Minimum denomination
200,000.00
USD
Coupon
7.13% (Fixed)
Yield to maturity
6.86%
Acts as a financing subsidiary/Special purpose entity
Show more
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.
Start trial